Dr. Minson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10310 Carleigh Ln
Roswell, GA 30076
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Vanderbilt University Medical CenterResidency, Pediatrics, 2009 - 2012
Medical University of South CarolinaClass of 2009
Pennsylvania State UniversityBS, Biochemistry and Molecular Biology, 2001 - 2005
Certifications & Licensure
GA State Medical License 2015 - 2025
CO State Medical License 2012 - 2017- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 109 citationsUNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.Weihe Zhang, Deborah DeRyckere, Debra Hunter, Jing Liu, Michael A. Stashko
Journal of Medicinal Chemistry. 2014-08-06 - 59 citationsThe MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia.Katherine A. Minson, Catherine C. Smith, Deborah DeRyckere, Clara Libbrecht, Alisa B. Lee-Sherick
JCI Insight. 2016-03-17 - 21 citationsThe small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis.Brian R. Branchford, Timothy J. Stalker, L. Law, Gilbert Acevedo, Susan Sather
Journal of Thrombosis and Haemostasis. 2018-01-12
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
